Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 7
Pfizer in talks on India plan; pacts, logistics may limit accessSubscriber Only
November 12, 2020 02:24 IST
With the scale required in India, it is expected that there may eventually be multiple vaccines deployed in the country, according to the firm.
Thu, Nov 12, 2020
After Pfizer, Sputnik V: Russia says Covid-19 vaccine shows 92% efficacySubscriber Only
November 11, 2020 17:30 IST
The findings of the trial are not yet peer-reviewed. But they are crucial for India, where the vaccine is being tested on humans in mid- to late-stage trials by Hyderabad-based Dr Reddy’s Laboratories.
Thu, Nov 12, 2020Pfizer Covid vaccine: Rollout logistics, potency likely speed bumpsSubscriber Only
November 11, 2020 03:00 IST
What makes quick scale up difficult is lack of data about how vaccine will react and will it work well in high-risk groups.
Wed, Nov 11, 2020
Pfizer claims first big breakthrough: test vaccine 90% effective in Phase 3Subscriber Only
November 10, 2020 03:03 IST
Pfizer and its partner, the German biotech company BioNTech, said the analysis of phase 3 trial data of the m-RNA vaccine candidate by an external independent Data Monitoring Committee (DMC) “has not reported any serious safety concerns”.
Tue, Nov 10, 2020
Explained: What next for Pfizer’s Covid-19 vaccine?Subscriber Only
November 09, 2020 18:52 IST
Covid-19 vaccine: Pfizer has reported that its vaccine, BNT162b2, has been more than 90 per cent effective in late-stage trials. How does it work, and what do the promising results mean for the US and other countries, including India?
Tue, Nov 17, 2020
An Expert Explains: Is lockdown the answer to another wave of Covid-19?Subscriber Only
November 09, 2020 03:24 IST
Large parts of Europe are in a second lockdown as a new wave of infection sweeps through the continent. But overall numbers in India are falling — for reasons not yet fully clear. What is the way forward, given the cost of lockdowns?
Fri, Jan 01, 2021
Explained: What is PLI scheme, and which sectors will be under it?Subscriber Only
November 08, 2020 04:33 IST
Apart from inviting foreign companies to set shop in India, the scheme also aims to encourage local companies to set up or expand existing manufacturing units.
Thu, Nov 12, 2020Covid opens pharma firms to threats: Lupin reports cyber attackSubscriber Only
November 07, 2020 04:02 IST
The threats from such digitisation were flagged last year, when cyber security solutions firm Kaspersky had reportedly ranked India as the sixth most vulnerable country where drugmakers were open to attacks from cyber criminals.
Sat, Nov 07, 2020
Biological E gets nod for human trialsSubscriber Only
November 05, 2020 02:23 IST
The nod of the Central Drugs Standard Control Organization (CDSCO) follows recommendations of an expert panel to allow the company to proceed with clinical trials of the vaccine candidate early last week.
Thu, Nov 05, 2020
Some districts trying to control the testing for Covid-19: Thyrocare MDSubscriber Only
October 29, 2020 04:30 IST
Thyrocare is among the top five diagnostic centres in the country, and has been collecting samples in several high Covid-19 caseload states including Maharashtra, Karnataka, Tamil Nadu, Bihar, West Bengal, Jammu and Kashmir, Jharkhand, Uttar Pradesh, Delhi, and Uttarakhand.
Thu, Oct 29, 2020
Dr Reddy’s looks to complete late-stage trials of Sputnik V by mid-May next yearSubscriber Only
October 29, 2020 00:53 IST
The firm, which will be conducting the testing here, expects to complete late-stage trials of the vaccine candidate by mid-May next year at the latest.
Thu, Oct 29, 2020
Covaxin: Bharat Biotech aims to improve clinical results by at least 60%, above regulator cut-off markSubscriber Only
October 29, 2020 00:50 IST
Bharat Biotech plans to test 25,000-26,000 volunteers in the third phase of its trials for Covaxin, which is expected to take place in sites across 12-14 states in India.
Thu, Oct 29, 2020
Bharat Biotech executive director: ‘Trying to raise manufacturing capacity above 500 million doses as soon as possible’Subscriber Only
October 26, 2020 04:06 IST
In an interview with The Indian Express, Bharat Biotech executive director Sai Prasad details the company’s discussions with the government to bring out the vaccine here, as well as its discussions with other countries to supply Covaxin globally.
Mon, Oct 26, 2020
Bharat Biotech says its ICMR-backed vaccine set for June 2021 launchSubscriber Only
October 24, 2020 04:50 IST
The approval for Bharat Biotech to conduct phase-3 trials currently puts it behind front-runner Serum Institute of India, which is said to be in the process of recruiting and vaccinating participants for the third phase of testing for its candidate, Covishield.
Sat, Oct 24, 2020
Explained: Is death in Brazil a blow for AstraZeneca-Oxford Covid-19 vaccine candidate?Subscriber Only
October 23, 2020 14:06 IST
A volunteer in Brazil participating in the trials for the Oxford University-AstraZeneca vaccine candidate, AZD1222, died this week. Does this mean the vaccine is unsafe? What happens to the trial?
Sat, Oct 31, 2020
Dr Reddy’s isolates data centre services after cyber attackSubscriber Only
October 23, 2020 04:39 IST
“In the wake of a detected cyber-attack, we have isolated all data centre services to take required preventive actions,” Dr Reddy's told the Bombay Stock Exchange on Thursday.
Fri, Oct 23, 2020
Late-Stage Trials: ‘Committed’ to mass vaccination, govt yet to finalise fund allocationSubscriber Only
October 23, 2020 01:09 IST
With various vaccine candidates progressing to late-stage human trials here, some experts feel the cost that the Centre will bear may become clearer by early 2021.
Fri, Oct 23, 2020Dr Reddy’s receives DCGI approval to conduct phase 2/3 trials of Sputnik V vaccine in IndiaSubscriber Only
October 17, 2020 17:17 IST
It is unclear at this stage how many participants will be enrolled in this trial and how many sites will be studying the vaccine's safety and ability to help develop an immune response against Covid-19.
Sun, Oct 18, 2020
Solidarity Trial dampener: What does this mean for the 4 drugs, including remdesivir?Subscriber Only
October 17, 2020 07:46 IST
Interim results of WHO’s Solidarity Trial show that none of the treatments studied could prove benefits across parameters. What does it mean for the drugs that hopes were pinned on, especially remdesivir?
Thu, Oct 22, 2020
Explained: Why WHO vs Gilead on Remdesivir mattersSubscriber Only
October 16, 2020 14:00 IST
What do the WHO Solidarity trial data say about the effectiveness of remdesivir? What is the drugmaker’s retort, and what does this mean for the treatment line for Covid-19?
Mon, Oct 19, 2020
Explained: What pause in Johnson & Johnson Covid-19 vaccine trial meansSubscriber Only
October 15, 2020 01:27 IST
After Oxford-AstraZeneca, Johnson & Johnson has now paused its vaccine trials — again on account of illness in a participant. Since both use the same platform, is this a pattern, or is it likely a coincidence?
Mon, Oct 19, 2020
AZD7442: A cocktail of antibodies to fight Covid-19Subscriber Only
October 14, 2020 09:21 IST
AZD7442, a similar class of the drug cocktail used to treat US President Donald Trump recently, is a combination of two long-acting monoclonal antibodies (LAAB). AstraZeneca developed it using its proprietary technology with the aim of preventing Covid-19 infection for a long duration.
Mon, Oct 19, 2020
Yet to be roped in, private cold chains start preparations for Covid immunisationSubscriber Only
October 13, 2020 04:46 IST
While the government continues to map cold chain capabilities for a Covid-19 vaccine roll out next year, some industry experts feel that the current capacity will have to at least be doubled.
Tue, Oct 13, 2020
Covid-19 vaccine candidates: Dr Reddy’s, Bharat Biotech, Bio E told to revise proposals for human trialsSubscriber Only
October 09, 2020 03:09 IST
In Bharat Biotech’s case, the SEC said that the design of the phase 3 trials for Covaxin were satisfactory “in principle”, except for their clarification on certain definitions like “asymptomatic” participants.
Fri, Oct 09, 2020
Explained: The experimental cocktail President Trump is taking for Covid-19Subscriber Only
October 03, 2020 18:01 IST
The cocktail is a combination of two monoclonal antibodies -- REGN10933 and REGN10987 -- designed “specifically” to block the infectivity of SARS-CoV-2.
Thu, Oct 08, 2020Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us